Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference on September 11-13, 2023
- None.
- None.
Dwight Egan, Company CEO, will be conducting a presentation discussing Company progress on its forthcoming Co-Dx PCR Home™ platform. The presentation can be accessed by clicking here or through the Events and Webcasts section of the Co-Diagnostics website on September 12, 2023 at 2:30 PM Eastern Time, for institutional investors and industry professionals who have registered for the event.
The Company will also be participating in one-on-one meetings, which can be arranged with H.C. Wainwright representatives.
The Co-Dx PCR Home platform is subject to FDA review and is not available for sale.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-participate-in-the-hc-wainwright-25th-annual-global-investment-conference-on-september-11-13-2023-301920689.html
SOURCE Co-Diagnostics
FAQ
What is the upcoming event that Co-Diagnostics, Inc. will be presenting at?
What will be discussed during the presentation?
When and where will the presentation be held?